Vanberra Signal

Aptum Biologics

Curated by Signal

Provider of software and services for the development of vaccines and antibodies

Overview

Provider of software and services for the development of vaccines and antibodies. EpiQuest is a software suite for analysis of linear protein sequence for the presence of B-cell, T-cell epitopes, and area complexity (immunological, functional) and EpiQuest-B is a program to detect within the linear sequence (presented in FASTA) areas of the highest probability to be immunogenic in a host and at the current stage, the matrix is based on immunogenicity for humans, mice, and rabbits. It has released 2 adjuvants namely ​IMMACCEL-R - adjuvant to accelerate immune response to an antigen in a T-cell-dependent manner and MAD which enhances the delivery of antigen to dendritic cells. It also provides research services for antibody development and vaccine formulation.

Key facts

Founded
2013

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Online platform offering health and wellness resources

    Health TechnologyLondon, United Kingdom
  • Provider of an online teleconsultation platform for multiple diseases

    Health TechnologyLondon, United Kingdom
  • Provider of expert-guided audio programs for sexual self-confidence

    Health TechnologyLondon, United Kingdom

About Aptum Biologics

What does Aptum Biologics do?

Provider of software and services for the development of vaccines and antibodies.

Where is Aptum Biologics headquartered?

Aptum Biologics is headquartered in Southampton, United Kingdom.

When was Aptum Biologics founded?

Aptum Biologics was founded in 2013.

Which sector is Aptum Biologics in?

Aptum Biologics operates in Health Technology.

Who are Aptum Biologics's competitors?

Companies similar to Aptum Biologics include Big Matters, HeadFloss, and Ferly.